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1. Introduction 
As a high proliferative ability cell line, embryonic stem (ES) cells can be propagated in 
undifferentiated state, while maintaining their pluripotency to form various kinds of adult 
tissue cells (Thomson et al., 1998). Under appropriate conditions, ES cells can from embryoid 
bodies (EBs) and subsequent differentiation into cardiacmyoctyes (CMs) that retain the 
function of excitability and spontaneous contractions (Wobus et al., 1991) (Maltsev et al., 
1994). These spontaneously beating cells contained in EBs have almost the same ion 
channels that control pacemaker function in the heart (He et al., 2003) (Yanagi et al., 2007).  
Although multipotent progenitors have previously been shown to give rise to CMs, smooth 
muscle, and endothelial cells, the mechanism governing the generation of large numbers of 
differentiated progeny remains poorly understood. Current research indicates that the level 
of differentiation is low and that few cultured EBs will ultimately convert into functional 
CMs (Norstrom et al., 2006). The potential use of ES cells to replace functional loss of 
particular tissues may depend on efficient differentiation protocols to derive tissue-specific 
cells. By manipulating the culture conditions in which ES cells differentiate, it has been 
possible to control and restrict the differentiation pathways and thereby generate cultures 
enriched in lineage-specific cells in vitro. Regulation of multipotent cardiac progenitor cell 
expansion and subsequent differentiation into CMs, smooth muscle or endothelial cells is a 
fundamental aspect of basic cardiovascular biology and cardiac regenerative medicine.  
More recently, direct reprogramming of adult somatic cells to become pluripotent ES-like 
cells (a.k.a. induced pluripotent stem cells, iPS cells) has been achieved. The cardiogenic 
potential of iPS cells is comparable to that of ES cells and that iPS-derived CMs (iPS-CMs) 
possess all fundamental functional elements of a typical cardiac cell, including spontaneous 
beating, hormonal regulation, cardiac ion channel expression and contractility. Therefore, 
iPS-CMs can be regarded as a potentially valuable source of cells for in vitro studies and 
cellular cardiomyoplasty (Pfannkuche et al., 2009). The availability of human ES cells and 
iPS cells, and their successful differentiation into genuine human cardiac cells have enabled 
researchers to gain novel insights into the early development of the human heart as well as 
to pursue the revolutionary paradigm of heart regeneration.  
                                                 
1 The first 2 authors contributed equally to this work.  
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2. Embryoid body formation 
There are two major ways for EB from ES cells in vitro: suspension culture and hanging 
drop methods. In suspension culture, ES cells will differentiate into aggregates known as 
EBs in a manner similar to the early embryo. Suspension methods allow spontaneous 
aggregation of EBs but usually give rise to heterogeneous cell clusters. The heterogeneous 
size and shape of EBs resulting from suspension culture can influence their differentiation 
potential. Hanging drop methods can provide relatively uniform EB size but technically 
challenge by limited number of EBs for characterization. Recently, other methods such as 
using spinner flasks and bioreactors for stirred-suspension culture have been utilized. 
Enhanced growth of EBs in spinner flasks has been reported due to effective nutrient and 
oxygen supply. In addition to stirred-suspension culture for scalable production of EBs can 
provide a readily available source of CMs (Lecina et al., 2010). These strategies have been 
shown to be advantageous compared to conventional suspension method due to their 
ability to control EB-EB interactions.  
Without induced differentiation, the differentiation level is low and that few cultured EBs 
will ultimately convert into functional CMs. Kehat et al. (Kehat et al., 2001) cultured human 
ES cells in suspension and plated to form aggregates termed EBs. Spontaneously contracting 
Cells appeared in only 8.1% of those EBs. Controlling the differentiating pathways 
permitting efficient generation of more mature and functional cells for basic studies or 
cardiac repair applications is a pressing need. As molecular mechanisms and signaling 
pathways leading to efficient differentiation from ES cells have not been understood and 
well-summarized, the potential factors that impact CM differentiation from ES cells include 
cell factors, drugs, hormone, culture method, and extracellular matrix.  
3. Cell factors and CM differentiation 
Schuldiner el at. (Schuldiner et al., 2000) examined the potential of eight growth factors 
including basic fibroblast growth factor (bFGF), transforming growth factor beta1 (TGF-
beta1), activin-A, bone morphogenic protein 4 (BMP-4), hepatocyte growth factor (HGF), 
epidermal growth factor (EGF), beta nerve growth factor (βNGF), and retinoic acid to direct 
the differentiation of human ES-derived cells in vitro. They found that the EBs differentiate 
selectively into mesodermal, endodermal, or ectodermal lineages. However, these studies 
did not result in homogeneous differentiation of ES cells.   
Many differentiating factors, including hepatocyte growth factor (HGF), transforming 
growth factor beta1 (TGF-β1), bone morphogenic protein (BMP)-2/4, and fibroblast growth 
factor (FGF) have been investigated in attempts to improve the efficiency of specific CM 
differentiation processes in mouse or human ES cells (Gassanov et al., 2004) (Roggia et al., 
2007)  (Schuldiner et al., 2000) (Ronca et al., 2009). These investigations have had some early 
encouraging results, but pluripotency and cellular differentiation are intricate biological 
processes that are coordinately regulated by a complex set of factors and epigenetic 
regulators, which need increasing research aiming to understand the molecular mechanisms 
that regulate stem cell differentiation.  
Growth factor signaling is required for cellular differentiation, tissue morphogenesis, and 
tissue homeostasis. Wnt proteins are one important family of growth factors and its 
signaling is an important regulator of differentiation and morphogenesis that can also 
control stem cell fates. Tran et al. (Tran et al., 2009) found that mesendoderm formation and 
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CM differentiation were enhanced by early and transient treatment of human ES cells with 
Wnt3a. The induction of mesoderm and subsequent cardiac differentiation from human ES 
cells requires fine-tuned cross talk between activin A/BMP4 and Wnt/beta-catenin 
pathways (Paige et al., 2010). Cripto is one of epidermal growth factors and its signaling 
pathway is recently reported as essential role for cardiac myogenesis in ES cells. D'Aniello et 
al.(D'Aniello et al., 2009) demonstrated that APJ/apelin in the Cripto signaling pathway 
governs mesoderm patterning and CM differentiation via activation of mitogen-activated 
protein kinase/p70S6 through coupling to a Go/Gi protein. Hypoxia failed to induce 
differentiation of mouse ES cells into CMs in the absence of Cripto-1 expression, 
demonstrating that Cripto-1 is required for hypoxia to fully differentiate mouse ES cells into 
CMs (Bianco et al., 2009). Phosphorylation of fibroblast growth factor receptor-1 is also 
reported as essential process required for CM differentiation in ES cells (Ronca et al., 2009). 
However, the differentiation of ES cells inevitably results in a heterogeneous mixture of cell 
types present in EBs. It would be more difficult to transform these into a homogenous 
population of CMs or to stop their differentiation at the functional CM stage. Neuregulin 
(NRG)-1beta/ErbB signaling regulates the ratio of nodal- to working-type cells in 
differentiating human ES cell-CM cultures and presumably functions similarly during early 
human heart development. By manipulating NRG-1beta/ErbB signaling, it will be possible 
to generate preparations of enriched working-type CMs (Zhu et al., 2010). Calreticulin may 
have a housekeeping role to play in mature CMs as well as during cardiomyogenesis. 
Calreticulin, an ER Ca (2+) storage protein, is a crucial regulator of cardiomyogenesis whose 
presence is required for controlled CM development from ES cells (Papp et al., 2009). Sik1 
(salt inducible kinase 1), a serine/threonine kinase that belongs to the stress- and energy-
sensing AMP-activated protein kinase family, involves in cardiac cell differentiation and/or 
heart development. Romito et al. (Romito et al., 2010) studied the role of sik1 in cardiac 
differentiation and found that sik1-mediated effects are specific for cardiomyogenesis 
regulating cardiomyoblast cell cycle exit toward terminal differentiation.  
MicroRNAs are a newly discovered endogenous class of small noncoding RNAs that play 
important posttranscriptional regulatory roles by targeting messenger RNAs for cleavage or 
translational repression. microRNAs as important transcriptional regulators may provide a 
new means of manipulating stem cell fate (Sartipy et al., 2009). By modulating miR-1 and -
499 expression levels, human ES cells function can be altered and differentiation directed, 
thereby enhancing cardiomyogenic differentiation (Sluijter et al., 2010). 
4. Drugs used for the CM differentiation of embryonic stem cells 
Dimethyl sulfoxide (DMSO), 5-azacytidine, retinoic Acid (RA), ascorbic acid have been 
investigated in attempts to improve the efficiency of CM differentiation processes in mouse 
or human ES cells (Paquin et al., 2002) (Yoon et al., 2006) (Drab et al., 1997) (Takahashi et al., 
2003). Recently, the synergy of these drugs in inducing ES cell differentiation into matured 
and functional CMs is quite attractive. Chan et al. (Chan et al., 2009) have investigated 
Salvianolic acid B-vitamin C synergy in cardiac differentiation from ES cells and found that 
Salvianolic acid B (saB)- ascorbic acid synergy improves ES cell differentiation into CMs.  
Recently, accumulating evidence points to reactive oxygen species (ROS) as important 
signaling molecules for CM differentiation from ES cells. Endogenous ROS control is 
important for CM formation from ES cells (Crespo et al., 2010). Nitric oxide (NO) has been 
shown to promote ES cell differentiation by increasing both the number and the size of 
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beating foci in EB outgrowths (Kanno et al., 2004). Exogenous electric fields have been 
implied in CM differentiation of mouse ES cells and the generation of ROS, which plays a 
role in CM differentiation of human ES cells, through mechanisms associated with the 
intracellular generation of ROS (Serena et al., 2009). 
5. Hormones used for the CM differentiation from embryonic stem cells 
Recent researches indicate there are some hormone receptors existing in ES cells, so 
hormone used as inductor to promote the CM differentiation from ES cells receives 
increasing attention. ES cells expressed cell surface kappa opioid receptors. The 
prodynorphin gene and its product, dynorphin B, have been found to promote 
cardiogenesis in embryonic cells by inducing the expression of GATA-4 and Nkx-2.5, two 
transcription factor-encoding genes essential for cardiogenesis (Ventura et al., 2003). 
Oxytocin receptor was discovered in undifferentiated ES cells and derived differentiated 
cells, which plays an important role in cardiogenesis by promoting CM differentiation. 
Treatment with oxytocin improves the EBs with spontaneous contraction, but has no effect 
on ultrastructural characteristics of CMs in any stage of development (Paquin et al., 2002) 
(Hatami et al., 2007). Thyroid hormone is essential for normal cardiac development and 
function, Lee et al. (Lee et al., 2010) showed that Thyroid (3) supplementation promotes 
cardiac differentiation of ES cells and enhances maturation of electrophysiological, as well 
as calcium homeostasis, properties of ES cell-derived CMs. 
6. Co-culture differentiation 
Although progress has been made towards differentiating stem cells to specific cell lineages, 
the efficiency is often poor and the number of cells generated is not suitable for therapeutic 
usage. Recent studies demonstrated that controlling the stem cell microenvironment can 
influence differentiation. As the differentiation of ES cells closes the development of the 
embryonic heart (Banach et al., 2003), factors that contribute to essential functions during 
early embryogenesis are expected to be involved in the formation of EBs (Behfar et al., 2002). 
However, the precise growth factor combinations that enhance cell differentiation in ES cells 
are unclear (Schuldiner et al., 2000). Consequently, ES cells are co-cultured with special cells 
or conditioned media to promote differentiation. For example, when ES cells are co-cultured 
with visceral-endoderm-like (END-2) cells, the majority (>90%) of the ES -CMs have a 
phenotype similar to fetal ventricular cells (Mummery et al., 2003). The efficiency of 
cardiogenic differentiation in ES cells can be readily enhanced by a culture medium that has 
been conditioned by END-2 cells (Graichen et al., 2008). Similarly, when medium 
conditioned by mouse embryo fibroblasts is used, the homogeneity of beating EBs can be 
significantly improved (Burridge et al., 2007).  
The niche in which stem cells reside and differentiate is a complex physicochemical 
microenvironment that regulates cell function. Local microenvironments are considered to 
be the key inducers in directing the site-specific differentiation of ES cells. Recently, it is 
reported that endothelial cell play an essential role in facilitating CM differentiation from 
pluripotent stem cells and regulate regeneration of CMs via EphB4 signaling (Chen et al., 
2010). Nevertheless, the effect and the mechanism of the cardiac microenvironment on the 
development of CM differentiation and EB growth have not yet been systematically studied. 
We developed a novel protocol to generate functional CMs from ES cells by an in vitro 
www.intechopen.com
Recent Advances in Controlling the Cardiacmyoctye Differentiation from Embryonic Stem Cells   
 
527 
indirect co-culture inducing strategy that looks promising for tissue engineering 
applications (fig.1). The propagation and CM differentiation of an ES cell line were studied 
in prolonged culture in this system (fig. 2). ES cells cultured on membranes by indirect co-
culture with native cardiac cells were significantly enhanced ES cells to differentiate into 
CMs that possessed expression of cardiac specific genes and functions of excitability and  
 
 
Fig. 1. The indirect co-culture system was used for CM differentiation from mouse ES cells.  
 
Fig. 2. The differentiation of embryonic stem cells (ES cells). 
(A) The percentage of embryoid bodies (EBs) with spontaneously contracting areas in 
control and co-culture groups during plating culture. 
(B) The in vitro differentiation process of ES cells in co-culture system. 
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Fig. 3. The expression of cardiac markers in ES cells. (A) OCT4, GATA4, Nkx2.5, ANF and 
CX43 expressions were almost increased in the co-culture system. (B),(C) Real time-PCR was 
performed to detect mRNA expressions of GATA and ANF in prolonged time course. *: 
P<0.05, **: P<0.01. (D),(E)  the protein expression of cardiac troponin I (cTnI) and connexin 
43 (Cx43) in co-culture system. 
spontaneous contractions (fig. 3). This co-culture system is a significant advance in ES cells 
culture methods, providing possibility to efficiently control the differentiation of ES cells 
and to more reliably obtain a large number of more mature and homogenous CMs for large-
scale tissue engineering applications and other stem cell-based regenerative medicine (Ou et 
al., 2009a).  
7. 2D vs. 3D differentiation 
Previously the most common model in vitro for cell research has been 2D monolayer 
culture. Even though EB has 3D structures, the researches on the differentiation of ES cells 
are mainly based on 2D cultured systems. However, these 2D cultured systems don’t mimic 
the physiological environment in vivo and may lead to low differentiated level of ES cells. 
Significant differences were found in the differentiation efficiency of ES cells when they 
were cultured in 2D and 3D environment (Liu et al., 2006). 
The extracellular microenvironment for 3D differentiation plays a significant role in regulating 
ES cells to differentiate into special lineages, as well as in cell migration and proliferation 
(Philp et al., 2005) (Chen et al., 2007). The extracellular matrix is in close contact with cells and 
involved in their maintenance and regulation. The mechanical and chemical signals (e.g., 
integrin signals) elicited by the extracellular matrix regulate the activities of cytoplasmic 
kinases, receptors for growth factor and ion channels, impacting differentiation of stem cells. 
Extracellular matrix proteins independently trigger differentiation of human mesenchymal 
stem cells and that differentiation in this context can be guided down multiple lineages using 
the same Extracellular matrix protein stimulus (Santiago et al., 2009). A new scalable 
bioprocessing system as a scalable platform for CM production has been developed (Lecina et 
al., 2010). Use of a 3-D cuboidal microwell system to culture human ES cells in colonies of 
defined dimensions, 100-500 microm in lateral dimensions and 120 microm in depth, enabled 
formation of more uniform-sized EBs. The regulation of microwell-engineered EB size can be 
used for more efficient and reproducible formation of human ES cell-CMs (Mohr et al., 2010). 
In addition, proliferation of stem cell-derived CMs appears to be regulated by microtopography 
through tension-generation of contractility in the third-dimension (Biehl et al., 2009). 
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Bioreactors, recent methods to achieve CM differentiation by engineering the stem cell 
microenvironment, are used to control the differentiation and produce large numbers of 
desired cells. Based on bioreactors, it is very likely to control the differentiation of ES cells: 
(1) biomaterials technology, biomaterials with different growth factors or morphogenetic 
factors delivery systems can be utilized to mimic embryogenic process, our unpublished 
data demonstrates that specific factors released from biomaterials via diffusion can enhance 
long-term survival and differentiation of ES cells, and (2) the use of bioreactors, cultivation 
in rotating bioreactors can promote and maintain CMs electrophysiology and molecular 
properties (Bursac et al., 2003).   
8. The potential applications 
The availability of ES and iPS cells and their successful differentiation into genuine human 
cardiac cells have enabled researchers to gain novel insights into the early development of 
the human heart as well as to pursue the revolutionary paradigm of heart regeneration. 
Their potential applications for ES cells in cardiac research area include developmental 
biology, functional genomics, pharmacological testing, cell therapy, organ regeneration, and 
biological pacemaker. 
8.1 Pharmacological testing 
Recent withdrawals of prescription drugs from clinical use because of unexpected side 
effects on the heart have highlighted the need for more reliable cardiac safety pharmacology 
assays. Human or mouse ES cell-derived CMs serve together as a valuable model for drug 
safety screening and advance preclinical drug development. Assays based on human ES 
cell-derived CMs could complement or potentially replace some of the preclinical cardiac 
toxicity screening tests currently used for lead optimization and further development of 
new drugs (Braam et al., 2010) (Liang et al., 2010). Human ES cell-derived CMs have been 
used to predicate of drug-induced cardiotoxicity, e.g., to study cardioprotective effects of 
dexamethasone in doxorubicin cardiotoxicity (Farokhpour et al., 2009) (Braam et al., 2010). 
8.2 Cell therapy 
ES cells, which can be differentiated into cardiac progenitors and CMs, represent a 
candidate cell source for cardiac cell therapy. However, it is not known what specific cell 
type or condition is the most appropriate for transplantation. It is reported that transplanted 
mouse ES cells in the infarcted heart inhibit apoptosis, fibrosis, and hypertrophy, thereby 
reducing adverse remodeling, resulting in the improvement of cardiac function (Singla et 
al., 2007) (Singla and McDonald, 2007) (Xie et al., 2007). Several recent studies have 
demonstrated that human ES cell-derived CMs survive after transplantation into infarcted 
rodent hearts, form stable cardiac implants, and result in preserved contractile function. To 
investigate the ischemic environment of host myocardium affects transplanted pluripotent 
cells, van Laake et al. (van Laake et al., 2009) cultured mouse ES cells in medium containing 
ischemic myocardial interstitial fluid (iMIF) and found that the ischemic/infarcted 
environment is favorable to stem cell-mediated angiogenesis, but hostile to cardiac 
myogenesis. These findings indicated mouse ES cell-mediated improvement of cardiac 
function after transplantation of pluripotent cells do not reflect remuscularization. Although 
cell transplantation has modestly improved cardiac function, major challenges including 
increasing cell survival, engraftment, and functional integration with host tissue.  
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8.3 Cardiac muscle regeneration 
Tissue-engineered cardiac muscle transplantation may have advantages over direct cell 
transplantation or replacement therapy for myocardial defect. The use of engineered heart 
tissue as a model system to accelerate development of cardiac cell therapy strategies has 
been demonstrated (Song et al., 2010). Human ES cell-derived CMs alone or with human 
endothelial cells (human umbilical vein endothelial cells) and embryonic fibroblasts 
(triculture constructs) were seeded onto biodegradable porous scaffolds. This tissue-
engineered human vascularized cardiac muscle have been established in vitro and 
transplanted in vivo to form stable grafts (Lesman et al., 2010b) . 
Effective engineering of viable thick complex tissue-constructs requires intense 
vascularization. More recently, a beating human cardiac muscle-construct containing an 
endothelial network was established by co-culturing human embryonic stem cell-derived-
CMs, fibroblasts, and endothelial cells within biodegradable scaffolds (Lesman et al., 2010a). 
The success of cardiac muscle regeneration and transplantation is dependent on a 
combination of several factors, such as: 1) the formation of new blood vessels, 2) the release 
of pro-survival, pro-angiogenic and anti-inflammatory factors (paracrine effect), and 3) the 
functional contribution of CMs and functional integration with host tissue.  
Components of the extracellular matrix are considered to be important physiological 
regulators and provide mechanical cues, direct differentiation and improve cell engraftment 
into damaged tissue. However, there are also adverse effects of scaffold materials, e.g. 
necrosis at the tissue core, low vascularization, and poor survival after transplantation. 
Scaffold-free for vascularized human cardiac muscle tissue that markedly improved 
viability after transplantation has been developed (Stevens et al., 2009). 
8.4 Biological pacemaker 
Sudden cardiac death due to abnormal heart rhythm from sick sinus syndrome kills millions 
of people each year, the reduction of the morbidity and mortality depends on how we can 
restore the generation of the cardiac impulse effectively. A conventional approach is 
implantation of electronic pacemakers, which are commonly used to treat cardiac impulse 
generation defects. However, there are many shortcomings for electronic pacemakers in 
clinical applications, such as the limited battery life, lack of catecholamine responsiveness, 
and associating with inconvenience in daily life (Rosen et al., 2004). Biological cardiac 
pacemaker, mimicking the sinoatrial node (SA-node), has been served as a promising way to 
restore the generation of the cardiac impulse for better alternative to the present routine.  
ES cells can be induced to differentiate into CMs with excitability and spontaneous 
contraction activities (Wobus et al., 1991) (Maltsev et al., 1994), which raises the prospect of 
the probable therapeutic application of ES cells in cardiac pacing. Their use as biological 
pacemakers has also been explored (Kehat et al., 2004) (Xue et al., 2005) (Menasche, 2004 ; 
Yanagi et al., 2007). Kehat et al. (Kehat et al., 2004) had discussed the potential of human ES 
cell-derived CMs to act as a rate-responsive biological pacemaker. The transplanted human 
ES cell-derived CMs can functionally integrate with other quiescent ventricular cells and 
pace the heart of swine with complete AV block, as assessed by detailed three-dimensional 
electrophysiological mapping and histopathological examination. Xue et al.’s work (Xue et 
al., 2005) was similar with Kehat’s. A functional human ES cell-derived pacemaker could be 
implanted in the left ventricle in vivo and successful spread of membrane depolarization 
was confirmed from surrounding myocardium in the site of injection. 
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Nevertheless, the use of ES cells in cardiac pacing is challenged by how to control the 
differentiation of ES cells and overcome the neoplasia, proarrhythmia or immunogenicity 
after transplantation. As a potential approach to solve these difficult problems, tissue 
engineering techniques may provide a precise control on the different cell components of 
multicellular aggregates and the forming construct with defined architectures and function 
properties (Ou et al., 2009b). For any biological pacemaker to be considered a potential 
medical therapy, it must functionally integrate with the heart and provide an impulse 
initiation enough and steady in the conducting system to ensure physiological activation of 
the heart. The applications of tissue engineering techniques not only provide a 3D 
environment for cells growth and expanding, but also provide structural support for higher 
order tissue organization and remodeling. The combined interactions among ES cell-derived 
pacemaker cells, supporting cells and matrices may result in a steady functional unit to 
induce rhythmic electrical and contractile activities and completely reproduce pacemaker 
properties. 
9. The challenges in stem cell research 
These investigations for ES cell differentiation have had some early encouraging results, but 
pluripotency and cellular differentiation are intricate biological processes that are 
coordinately regulated by a complex set of factors and epigenetic regulators, which need 
increasing research aiming to understand the molecular mechanisms that regulate stem cell 
differentiation. The major direction of human ES cell use is derivation of a specific 
differentiated progeny, which has lower proliferative potential and immune privilege, yet 
poses fewer risks. There is report that immaturity of the sarcoplasmic reticulum and the 
beta-adrenergic response can be found in CMs from ES Cells and iPS cells (Xi et al., 2010). 
The heterogeneity in electrical properties of the human ES cell-CMs is exist (Pekkanen-
Mattila et al., 2010).  
Pluripotent stem cell biology and technology is in need of further investigation and 
development. The development of efficient and reproducible culture systems for culturing 
ES cells in complete xeno-free conditions to reduce the risk of cross-transfer of pathogens 
without loss pluripotency is an essential pre-requisite for regenerative medicine. Synthetic, 
xeno-free, scalable surfaces that support the self-renewal and differentiation of ES Cells and 
iPS cells will be useful for both research purposes and development of cell therapies 
(Melkoumian et al., 2010).  
Efficiently controlling the differentiation of ES Cells to produce more mature and 
homogenous CMs is currently the most challenging task. Thus, a future challenge will be to 
design strategies that eventually may allow the cells to reach a higher degree of maturation 
in vitro.  
The recent development of reprogramming of differentiated human somatic cells to iPS cells 
should overcome ethics obstacles and facilitate clinical applications of stem cells. The most 
advantages of reprogramming is that it allows the establishment of patient- and disease-
specific in vitro models of human hereditary diseases for pathophysiologic and 
developmental studies. However, although human ES cells and human iPS cells have been 
shown to share a number of similarities, there are still differences electrophysiology 
properties between human ES cells and human iPS cells (Jiang et al., 2010). It has been 
showed that foreign genes were silenced or removed after reprogramming, but those 
approaches have low reprogramming efficiency, and either leave residual vector sequences, 
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or require tedious steps. Whether reprogramming methods can be improved will depend on 
a better understanding on the molecular cell biology of pluripotent stem cells.  
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